AADI
Companies
NASDAQ
Aadi Bioscience Inc.
Health Care
$2.01
-$1.15 (-36.29%)
Price Chart
Overview
About AADI
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
Market Cap
$42.7M
Volume
230.9K
Avg. Volume
349.0K
P/E Ratio
-2.029703
Dividend Yield
0.00%
Employees
45.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.99
Moderate Correlation
Volatility
High (0.89)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, AADI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$42.7M
Volume230.9K
P/E Ratio-2.03
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
November 6, 2024Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025